Job Title: Global Director Market Development and Strategy – Sickle Cell Disease Location: Cambridge, MA About the... Job This individual’s primary role is commercial accountability for the Rilzabrutinib global market development strategy and market...
Job Description Director, Market Access Strategy, T1D Location: Boston, MA (3 days onsite, 2 days remote weekly... developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF), Sickle Cell Disease, Transfusion...
Nephropathy (IgAN), APOL-1 Mediated Kidney Disease, among others. The Director, Market Access Strategy Lead – AMKD (inaxaplin... developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF), Sickle Cell Disease and Transfusion...
, and autosomal dominant polycystic kidney disease. General Summary: The Senior Director, Global Commercial Strategy CF Pipeline... that treat the underlying cause of cystic fibrosis (“CF”), a life-threatening genetic disease, one that treats severe sickle cell...
developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF), Sickle Cell Disease, Transfusion... market access, trade and distribution Previous channel distribution experience with cell and gene therapy, rare disease...
has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it... – US Market Access fellowship, based in Boston, MA. About Vertex Vertex is a global biotechnology company that invests...
, a gene therapy for sickle cell disease and beta-thalassemia, and JOURNAVX, the first new class of medicine for moderate... mechanisms of serious diseases, including B cell-mediated renal diseases, APOL-1 mediated kidney disease (AMKD), chronic pain, DM...